Related Experiment Videos
Purification of antibodies using protein L-binding framework structures in the light chain variable domain
B H Nilson1, L Lögdberg, W Kastern
1Department of Medical and Physiological Chemistry, University of Lund, Sweden.
Journal of Immunological Methods
|August 26, 1993
Summary
Protein L, a bacterial protein, can purify various immunoglobulins (IgG, IgM, IgA) and antibody fragments. Engineered antibodies with protein L-binding regions facilitate streamlined purification processes.
Area of Science:
- Biochemistry
- Immunology
- Protein Engineering
Background:
- Protein L, derived from Peptostreptococcus magnus, exhibits specific binding to the variable domain of immunoglobulin (Ig) light chains.
- This interaction does not impede the antigen-binding site of the Ig molecule.
Purpose of the Study:
- To utilize a genetically engineered fragment of Protein L for the purification of immunoglobulins from diverse sources.
- To demonstrate the feasibility of engineering antibodies and antibody fragments for Protein L-based purification.
Main Methods:
- Affinity chromatography using Protein L-Sepharose was employed for Ig purification.
- Purification was performed on various Ig isotypes (IgG, IgM, IgA) from human and mouse serum.
- Protein L-Sepharose was also used to purify monoclonal antibodies, antibody fragments (Fab), and recombinant antibodies from cell cultures.
Main Results:
- Single-step purification of IgG, IgM, and IgA from human and mouse serum was achieved.
- Purification of monoclonal antibodies, Fab fragments, and chimeric antibodies from hybridoma and bacterial cell cultures was successful.
- Humanized antibodies with engineered Protein L-binding framework regions were purified using this method.
Conclusions:
- Protein L-Sepharose is an effective tool for the single-step purification of various immunoglobulins and antibody fragments.
- Antibodies and antibody fragments can be engineered to incorporate Protein L-binding regions.
- This engineering enables the application of Protein L-based purification protocols for a wider range of antibody formats.